FLFan Lin

Fan Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fan Lin has a total of 200 co-authors. Here are the top co-authors by number of shared publications:

  • Pengli Zhu

    Shengli Clinical Medical College of Fujian Medical University Fuzhou China

    20 shared publications
  • Yongxing Lai

    Department of Geriatric Medicine, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China

    8 shared publications
  • Dan-Dan Ruan

    Department of Traditional Chinese Medicine and Nephrology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China

    6 shared publications
  • Jian-Hui Zhang

    Department of Traditional Chinese Medicine and Nephrology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China

    6 shared publications
  • Jie-Wei Luo

    Fuzhou University Affiliated Provincial Hospital, College of Chemistry, Fuzhou University

    6 shared publications
  • Chunjin Lin

    Shengli Clinical Medical College of Fujian Medical University

    5 shared publications

Latest Publications

  • Open Access

    Knowledge, attitudes, and practices of healthcare professionals regarding palliative care family meetings: a multicenter cross-sectional study

    by Chunjin Lin, Xiaona Zheng, Fang Zhu, Chengying Li, Yifang Guo, Fan Lin, Pengli Zhu

    Background: To assess the knowledge, attitudes, and practices (KAP) of healthcare professionals (HP) regarding palliative care family meetings and to identify factors independently associated with practice level. Methods: This multicenter cross-sectional study was conducted among 401 healthcare professionals across four institutions in Fujian Province between January and February 2026. Data were collected using a validated self-designed questionnaire encompassing demographic characteristics and KAP scores. Multivariable logistic regression identified factors independently associated with practice level, and structural equation modeling (SEM) examined whether attitude mediated the knowledge-practice relationship. Results: The mean scores were 14.35 ± 5.95 for perceived knowledge (55.2% of maximum), 42.63 ± 5.92 for attitude (85.3%), and 24.96 ± 8.93 for practice (71.3%). Multivariable analysis identified knowledge score (OR = 1.088, 95%CI: 1.046–1.132, p < 0.001), attitude score (OR = 1.063, 95%CI: 1.023–1.104, p = 0.002), and monthly income 10,000 RMB (OR = 0.448, 95%CI: 0.217–0.923, p = 0.029) as independent associates of proactive practice. SEM indicated that attitude partially mediated the perceived knowledge-practice relationship (indirect effect β = 0.052, p = 0.003), with knowledge also showing a significant direct association with practice ( β = 0.277, p = 0.010). Conclusion: Healthcare professionals in Fujian Province demonstrated limited perceived knowledge but positive attitudes and proactive practices toward palliative care family meetings. Both perceived knowledge and attitude were independently associated with practice, with attitude serving as a partial mediator. Targeted training programs and institutional support are needed to translate positive attitudinal endorsement into consistent, high-quality practice.

  • Open Access

    Multi-omics analysis and experimental validation reveal the IRF7-CXCL10 axis as a master regulator of microglial PCD in ischemic stroke

    by Yongxing Lai, Peiqiang Lin, Kexin Zhang, Wenyao Hong, Mouwei Zheng, Lijuan Wu, Tin Chen, Fan Lin

    Background Microglia-driven neuroinflammation serves as a critical factor in secondary injury following ischemic stroke, yet the primary regulators governing detrimental microglial phenotypes remain unclear. As a key component of this process, the cell type-specific regulatory mechanisms of programmed cell death (PCD) are poorly understood. Methods We performed an integrative analysis of public single-cell and bulk transcriptomic datasets from a murine stroke model. A multi-layered computational pipeline, incorporating pseudotime trajectory, weighted co-expression network analysis (WGCNA), and gene regulatory network inference (SCENIC), was used to identify master regulators of PCD. Functional validation was conducted using in vitro oxygen–glucose deprivation/reoxygenation (OGD/R) on primary microglia-neuron co-cultures and in vivo via a transient middle cerebral artery occlusion (tMCAO) model, employing AAV-mediated microglia-specific gene silencing, comprehensive in vitro and in vivo rescue strategies, and detailed behavioral assessments. Results Our single-cell analysis identified microglia as the central hub of PCD activity post-stroke. An unbiased, multi-layered computational pipeline converged upon Interferon Regulatory Factor 7 (IRF7) as the master transcriptional regulator of this high-PCD, pathological microglial state. We confirmed IRF7 upregulation in microglia following ischemic injury and delineated a novel downstream pathway where IRF7 directly binds the CXCL10 promoter to drive its expression, promoting microglial dysfunction and neurotoxicity. In vitro, silencing IRF7 skewed microglia toward an anti-inflammatory phenotype and protected co-cultured neurons from apoptosis. Critically, microglia-specific IRF7 knockdown in vivo significantly reduced infarct volume, suppressed neuronal death, and led to significant improvements in long-term neurological and cognitive function after stroke. Crucially, both in vitro genetic overexpression of CXCL10 and in vivo administration of recombinant CXCL10 completely abolished the neuroprotective benefits of IRF7 inhibition, establishing a definitive functional causality for the IRF7-CXCL10 axis. Conclusion Our findings uncover the IRF7-CXCL10 axis as a pivotal driver of detrimental neuroinflammation in ischemic stroke and establish IRF7 as a potent therapeutic target for neuroprotection.


  • Open Access

    Dietary rhythms and biological aging risk across multiple organs

    by Luyan Zheng, Zhilong Jia, Shuanghui Gong, Tian Zheng, Yizhou Zhuang, Lan Lin, Qianwen Li, Fan Lin, Meixia Ren

    The effects of dietary rhythms on organ-specific biological aging remain unclear. This study analyzed 14,012 adults from NHANES to assess associations between dietary rhythms and biological aging of the body, heart, liver, and kidneys. Earlier last meals, specifically before 9 p.m., were linked to lower aging risks for the body, heart, and liver but not kidneys. The strongest protective effects were seen with meals between 3 and 5 p.m. for the body and heart, and 5-7 p.m. for the liver. Conversely, later first meals and longer feeding durations (>8 h) linked to higher aging risks. These associations were modified by age, gender, disease status, caloric intake and dietary quality, with effects more pronounced in individuals over 40, males, and those without existing diseases or with low calorie intake. Delayed first and earlier last meal remained significantly associated with body and liver aging in the healthy diet group, whereas heart aging showed stronger associations with meal time in the unhealthy diet group. This study revealed optimal meal timing and duration differ for biological aging across different organs, ages, genders, disease status, energy intake, and dietary quality, highlighting a critical food-nutrient-timing synergy, and the need for personalized nutritional guidance and population-specific dietary strategies.

  • Open Access

    ApoE4 Drives Microglial Lipid Dysregulation in Alzheimer’s Disease via Epigenetic Reprogramming of the Asxl1/LXRα–H3K4me3 Axis

    by Lanyan Lin, Zhen Pan, Zhen Wei, Xiulong Jiang, Yongxing Lai, Mingfeng Chen, Fan Lin

    The ε4 allele of apolipoprotein E gene (APOE) stands as the greatest genetic risk factor for late-onset Alzheimer’s disease (AD). Although micro


  • Open Access

    A novel NOTCH1 nonsense variant in a bicuspid aortic valve family with intrafamilial clinical heterogeneity

    by Qian Chen, Zi-Yan Xu, Wu Chi, Xiang Chen, Jing Zou, Ting Chen, Meng-Qian Wu, Dan-Dan Ruan, Hong-Ping Yu, Jian-Hui Zhang, et al.

    Bicuspid aortic valve (BAV) represents a prevalent form of congenital heart disease. The NOTCH1 gene is implicated in the pathogenesis of BAV, and congenital valve anomalies caused by variants in this gene are classified as Aortic Valve Disease 1 (AOVD1), which is inherited in an autosomal dominant pattern. Echocardiographic data and peripheral blood samples were collected from a Chinese family manifesting a clinical phenotype characterized by various cardiovascular abnormalities, including BAV. Exome sequencing target enrichment technology was performed to identify candidate genes and variants. This was followed by family segregation analysis using Sanger sequencing. A novel nonsense variant, c.2266G > T (p.Glu756Ter), was identified in the NOTCH1 gene (NM_017617.5) within this family. Individuals harboring the p.Glu756Ter pathogenic variant (III4, II7, II9, and I2) exhibited BAV – associated phenotypes. Conversely, the proband carrying p.Glu756Ter pathogenic variant (IV1) presented with distinct clinical phenotypes, including a persistent left superior vena cava (PLSVC) and a widened coronary sinus. Family members without the p.Glu756Ter pathogenic variant showed no cardiovascular abnormalities. This variant is located in exon 14 of the NOTCH1 gene, resulting in a premature stop codon. Bioinformatics analysis predicted that p.Glu756Ter induces nonsense-mediated mRNA decay or produces a truncated protein, impairing NOTCH1 receptor function. The NOTCH1 variant is a prevalent genetic factor in BAV etiology, exhibiting both interfamilial and intrafamilial phenotypic variability with incomplete penetrance. PLSVC and a widened coronary sinus represent common anatomical variations within the general population. Nevertheless, the potential role of NOTCH1 variants in the development of these vascular anomalies should be considered.

  • Restoring Retinoic Acid: Alleviating Autism-Like Behaviors in Sox5-Deficient Mice

    by Lanyan Lin, Yongxing Lai, Ainong Mei, Yan Chen, Fan Lin

  • Open Access

    Translational computerized clinical decision support systems for Alzheimer's disease: A systematic review

    by Pinya Lu, Mingfeng Chen, Lili Chen, Fan Lin, Hongqin Yang, Yuhua Wang, Xuemei Ding

    Background: Alzheimer's disease (AD), marked by progressive memory loss and cognitive decline, poses diagnostic challenges due to its multifactorial nature. Therefore, researchers are increasingly leveraging artificial intelligence and data-driven approaches to develop computerized clinical decision support systems (CCDSS), aiming to enhance early detection, improve treatment, and slow disease progression. Objective: This study seeks to conduct a systematic review of the most recently developed AD-CCDSS, delving into their progress and the challenges to guide future development and implementation of CCDSS for AD-related decision-making and intervention strategies. Methods: We follow the PRISMA 2020 guideline to search for articles published within the past seven years across PubMed, ScienceDirect, IEEE Xplore Digital Library, Web of Science, and Scopus, with Google Scholar as a supplementary source. Key components are then extracted from the selected studies for qualitative analysis, including data modalities, computational modeling approaches, system explainability and interpretability, research priorities, and graphical user interfaces designed for non-technical stakeholders. Results: After searching and removing duplicates, we meticulously selected 55 studies. After reviewing key components of CCDSS, we highlight advancements and potential clinical applications, demonstrating their promise in enhancing decision support. However, despite growing attention to explainability in AD-CCDSS, its clinical applicability remains limited. Moreover, challenges such as multi-center system interoperability and data security remain underexplored, hindering real-world implementation. Conclusions: This study analyzes recent translational AD-CCDSS, identifying key challenges in advancing CCDSS for clinical applications. It offers insights for researchers to enhance CCDSS development and facilitate their integration into clinical practice.


  • Open Access

    IFI204 in microglia mediates traumatic brain injury-induced mitochondrial dysfunction and pyroptosis via SENP7 interaction

    by Ting Guo, Yongxing Lai, Shuguang Wu, Chunjin Lin, Xinyu Zhou, Peiqiang Lin, Mouwei Zheng, Jianhao Chen, Fan Lin

    Objectives Traumatic brain injury (TBI) is a primary contributor to chronic functional impairment in human populations, initiating complex neuroinflammatory cascades and neurodegeneration. Despite extensive research efforts, the precise pathophysiological pathways remain incompletely characterized. This investigation aims to establish a novel therapeutic strategy that targets critical molecular pathways post-injury, potentially addressing the current limitations in the clinical management of TBI patients. Methods The single-cell data of cortical tissue from mice with TBI were obtained from public databases (GSE160763), which was utilized to identify alterations in in the composition of disease-associated cells and related molecules as the disease progresses. Functional and pathway enrichment analyses were conducted to elucidate the functional characteristics of microglia and astrocyte subpopulations. Trajectory analysis was employed to investigate cell differentiation characteristics. Subsequently, we examined the expression and function of microglia-specific molecules, such as IFI204, along with their underlying molecular mechanisms using Western blotting, immunofluorescence, co-immunoprecipitation (CO-IP), histopathology, behavioral tests, and molecular docking to assess binding status, as well as molecular dynamics simulations. Finally, we used molecular docking technology to find small molecule compounds that IFI204 can stably bind to. Results We identified nine major cell populations, most of which undergo dynamic changes following TBI. Astrocytes and microglia were the predominant populations in each group, and further cluster analysis revealed that the proportions of interferon (IFN) and axonogenesis-related microglial subtypes increased after TBI. Trajectory inference analysis indicated that the expression of Ifi204 is upregulated in microglia during disease progression. Conditional microglial knockdown of IFI204 significantly improved neurological deficits in mice, and alleviated mitochondrial dysfunction and microglial pyroptosis. Mechanistically, SENP7, identified as a novel molecule, interacts with IFI204 in microglia, catalyzes the deSUMOylation of IFI204, and promotes STING signal activation, ultimately driving microglial pyroptosis and mitochondrial dysfunction. Conclusions The interaction between IFI204 and SENP7 promotes microglial pyroptosis and related mitochondrial dysfunction. Furthermore, in the case of TBI, we hypothesize that targeting IFI204 might yield therapeutic benefits.


  • Open Access

    Analysis of low-density lipoprotein receptor gene mutations in a family with familial hypercholesterolemia

    by Ya-Nan Hu, Min Wu, Hong-Ping Yu, Qiu-Yan Wu, Ying Chen, Jian-Hui Zhang, Dan-Dan Ruan, Yan-Ping Zhang, Jing Zou, Li Zhang, et al.

    Background: Familial hypercholesterolemia (FH) is a common monogenic autosomal dominant disorder, primarily mainly caused by pathogenic mutations in the low-density lipoprotein receptor (LDLR) gene. Through phenotypic-genetic linkage analysis, two LDLR pathogenic mutations were identified in FH families: c.G1027A (p.Gly343Ser) and c.G1879A (p.Ala627Thr). Materials and methods: Whole exome sequencing was conducted on the proband with familial hypercholesterolemia to identify the target gene and screen for potential pathogenic mutations. The suspicious responsible mutation sites in 14 family members were analyzed using Sanger sequencing to assess genotype-phenotype correlations. Mutant and wild type plasmids were constructed and transfected into HEK293T cells to evaluate LDLR mRNA and protein expression. In parallel, bioinformatics tools were employed to predict structural and functional changes in the mutant LDLR. Results: Immunofluorescence analysis revealed no significant difference in the intracellular localization of the p.Gly343Ser mutation, whereas protein expression of the p.Ala627Thr mutation was decreased and predominantly localized in the cytoplasm. Western blotting has showed that protein expression levels of the mutant variants were markedly declined in both cell lysates and supernatants. Enzyme linked immunosorbent assay has demonstrated that LDLR protein levels in the supernatant of cell culture medium was not significant different from those of the wild-type group. However, LDLR protein levels in the cell lysate of both the Gly343Ser and Ala627Thr variants groups were significantly lower than those in the wild-type group. Bioinformatic predictions further suggested that these mutations may affect post-translational modifications of the protein, providing additional insight into the mechanisms underlying the observed reduction in protein expression. Conclusions: In this study, we identified two heterozygous pathogenic variants in the LDLR gene, c.G1027A (p.Gly343Ser) and c.G1879A (p.Ala627Thr), in a family with familial hypercholesterolemia. We also conducted preliminary investigations into the mechanisms by which these mutations contribute to disease pathology.